Glioblastoma (GBM) is the most malignant IV grade [according to The World Health Organization (WHO)] primary central nervous system tumour with a particularly poor outcome. Median survival without treatment is approximately a year, with radiotherapy and chemotherapy 5-year survival rates are 60% to 80%.
Journal of Molecular and Cellular Biochemistry received 22 citations as per Google Scholar report